Trials / Completed
CompletedNCT00656305
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic and Multiple Myeloma Bone Tumors for the Palliation of Pain in Patients Who Are Not Candidates for Radiation Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 147 (actual)
- Sponsor
- InSightec · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone and Multiple Myeloma Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ExAblate MRfFUS | MR guided focused ultrasound. |
| DEVICE | Sham | sham comparator |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2008-04-11
- Last updated
- 2020-02-05
- Results posted
- 2018-11-14
Locations
14 sites across 5 countries: United States, Canada, Israel, Italy, Russia
Source: ClinicalTrials.gov record NCT00656305. Inclusion in this directory is not an endorsement.